| 5401 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
35 |
| 5402 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
70 |
| 5403 |
Apheresis |
Allogeneic
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
57 |
| 5404 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
41 |
| 5405 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
60 |
| 5406 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
68 |
| 5407 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
65 |
| 5408 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
63 |
| 5409 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
65 |
| 5410 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
66 |
| 5411 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
57 |
| 5412 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
65 |
| 5413 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
67 |
| 5414 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
64 |
| 5415 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
70 |
| 5416 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
64 |
| 5417 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
66 |
| 5418 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
68 |
| 5419 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
58 |
| 5420 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
59 |
| 5421 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
72 |
| 5422 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
65 |
| 5423 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
62 |
| 5424 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
55 |
| 5425 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
62 |
| 5426 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
14 |
| 5427 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
61 |
| 5428 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
61 |
| 5429 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
75 |
| 5430 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
45 |
| 5431 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
70 |
| 5432 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
72 |
| 5433 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
69 |
| 5434 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
45 |
| 5435 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
40 |
| 5436 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
65 |
| 5437 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
72 |
| 5438 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
50 |
| 5439 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
59 |
| 5440 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
66 |
| 5441 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
61 |
| 5442 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
42 |
| 5443 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
68 |
| 5444 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
65 |
| 5445 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
56 |
| 5446 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
63 |
| 5447 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
62 |
| 5448 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
64 |
| 5449 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
42 |
| 5450 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
68 |
| 5451 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
61 |
| 5452 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
68 |
| 5453 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
62 |
| 5454 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
66 |
| 5455 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
66 |
| 5456 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
67 |
| 5457 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
4 |
| 5458 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
56 |
| 5459 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
66 |
| 5460 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
62 |
| 5461 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
61 |
| 5462 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
61 |
| 5463 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
63 |
| 5464 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
44 |
| 5465 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
45 |
| 5466 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
33 |
| 5467 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
66 |
| 5468 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
65 |
| 5469 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
49 |
| 5470 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
69 |
| 5471 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
71 |
| 5472 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
25 |
| 5473 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
42 |
| 5474 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
46 |
| 5475 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
65 |
| 5476 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
49 |
| 5477 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
66 |
| 5478 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
64 |
| 5479 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
67 |
| 5480 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
66 |
| 5481 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome – Raeb
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
21 |
| 5482 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome – Raeb
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
16 |
| 5483 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome; Myeloproliferative Neoplasms Overlap
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
64 |
| 5484 |
Apheresis |
Allogeneic
|
Myelofibrosis
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
46 |
| 5485 |
Apheresis |
Allogeneic
|
Myelofibrosis
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
62 |
| 5486 |
Apheresis |
Allogeneic
|
Myelofibrosis
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
47 |
| 5487 |
Apheresis |
Allogeneic
|
Myelofibrosis
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
33 |
| 5488 |
Apheresis |
Allogeneic
|
Myelofibrosis
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
45 |
| 5489 |
Apheresis |
Allogeneic
|
Myelofibrosis
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
43 |
| 5490 |
Apheresis |
Allogeneic
|
Myelofibrosis With Myeloid Metaplasia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
66 |
| 5491 |
Apheresis |
Allogeneic
|
Myelofibrosis With Myeloid Metaplasia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
69 |
| 5492 |
Apheresis |
Allogeneic
|
Myelofibrosis With Myeloid Metaplasia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
63 |
| 5493 |
Apheresis |
Allogeneic
|
Myelofibrosis With Myeloid Metaplasia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
61 |
| 5494 |
Apheresis |
Allogeneic
|
Myelofibrosis With Myeloid Metaplasia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
61 |
| 5495 |
Apheresis |
Allogeneic
|
Myeloma Multiplex
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
45 |
| 5496 |
Apheresis |
Allogeneic
|
Myeloma Multiplex
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
62 |
| 5497 |
Apheresis |
Autologous
|
Myeloma; Amyloidosis
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
47 |
| 5498 |
Apheresis |
Autologous
|
Natural Killer / T-Cell-Non-Hodgkin-Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
32 |
| 5499 |
Apheresis |
Allogeneic
|
No Data
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
43 |
| 5500 |
Apheresis |
Allogeneic
|
No Data
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
20 |